Nana Kusi Minkah

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front Paris, March 20, 2025. – Sanofi and Dren Bio, […]

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Read More »

Mission BioCapital Announces Team Promotions and New Hires

CAMBRIDGE, Mass., February 5, 2025 — We are proud to announce today that we have promoted three Mission BioCapital (MBC) investment professionals and extended our capabilities by adding three new team members. “In recognition of their contributions and value to our team, we are so pleased to have promoted Cassidy Blundell and Zach Collins to

Mission BioCapital Announces Team Promotions and New Hires Read More »